285 related articles for article (PubMed ID: 2470148)
1. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines.
Poli G; Orenstein JM; Kinter A; Folks TM; Fauci AS
Science; 1989 May; 244(4904):575-7. PubMed ID: 2470148
[TBL] [Abstract][Full Text] [Related]
2. Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells.
Biswas P; Poli G; Kinter AL; Justement JS; Stanley SK; Maury WJ; Bressler P; Orenstein JM; Fauci AS
J Exp Med; 1992 Sep; 176(3):739-50. PubMed ID: 1512539
[TBL] [Abstract][Full Text] [Related]
3. Alpha interferon suppresses virion but not soluble human immunodeficiency virus antigen production in chronically infected T-lymphocytic cells.
Fernie BF; Poli G; Fauci AS
J Virol; 1991 Jul; 65(7):3968-71. PubMed ID: 1710293
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human immunodeficiency virus type 1 morphogenesis in T cells by alpha interferon.
Smith MS; Thresher RJ; Pagano JS
Antimicrob Agents Chemother; 1991 Jan; 35(1):62-7. PubMed ID: 1707604
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage.
Poli G; Kinter AL; Justement JS; Bressler P; Kehrl JH; Fauci AS
J Exp Med; 1991 Mar; 173(3):589-97. PubMed ID: 1705278
[TBL] [Abstract][Full Text] [Related]
6. Loss of infectivity by progeny virus from alpha interferon-treated human immunodeficiency virus type 1-infected T cells is associated with defective assembly of envelope gp120.
Hansen BD; Nara PL; Maheshwari RK; Sidhu GS; Bernbaum JG; Hoekzema D; Meltzer MS; Gendelman HE
J Virol; 1992 Dec; 66(12):7543-8. PubMed ID: 1279206
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of HIV-1 transmission by interferon and 3'-azido-3'-deoxythymidine during de novo infection of promonocytic cells.
Dubreuil M; Sportza L; D'Addario M; Lacoste J; Rooke R; Wainberg MA; Hiscott J
Virology; 1990 Nov; 179(1):388-94. PubMed ID: 1699354
[TBL] [Abstract][Full Text] [Related]
8. Soluble tumor necrosis factor receptors inhibit phorbol myristate acetate and cytokine-induced HIV-1 expression chronically infected U1 cells.
Granowitz EV; Saget BM; Angel JB; Wang MZ; Wang A; Dinarello CA; Skolnik PR
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(5):430-7. PubMed ID: 8605587
[TBL] [Abstract][Full Text] [Related]
9. A platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cells.
Weissman D; Poli G; Bousseau A; Fauci AS
Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2537-41. PubMed ID: 7681601
[TBL] [Abstract][Full Text] [Related]
10. Synergistic drug interactions of an HIV-1 protease inhibitor with AZT in different in vitro models of HIV-1 infection.
Lambert DM; Bartus H; Fernandez AV; Bratby-Anders C; Leary JJ; Dreyer GB; Metcalf BW; Petteway SR
Antiviral Res; 1993 Aug; 21(4):327-42. PubMed ID: 7692816
[TBL] [Abstract][Full Text] [Related]
11. Two-drug combinations of zidovudine, didanosine, and recombinant interferon-alpha A inhibit replication of zidovudine-resistant human immunodeficiency virus type 1 synergistically in vitro.
Johnson VA; Merrill DP; Videler JA; Chou TC; Byington RE; Eron JJ; D'Aquila RT; Hirsch MS
J Infect Dis; 1991 Oct; 164(4):646-55. PubMed ID: 1716649
[TBL] [Abstract][Full Text] [Related]
12. Valproic acid reduces the intracellular level of glutathione and stimulates human immunodeficiency virus.
Simon G; Moog C; Obert G
Chem Biol Interact; 1994 Jun; 91(2-3):111-21. PubMed ID: 7514959
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Tat function in human immunodeficiency virus type 1-infected low-level-expression cell lines U1 and ACH-2.
Cannon P; Kim SH; Ulich C; Kim S
J Virol; 1994 Mar; 68(3):1993-7. PubMed ID: 8107261
[TBL] [Abstract][Full Text] [Related]
14. Restriction of HIV replication in infected T cells and monocytes by interferon-alpha.
Gendelman HE; Baca L; Turpin JA; Kalter DC; Hansen BD; Orenstein JM; Friedman RM; Meltzer MS
AIDS Res Hum Retroviruses; 1990 Aug; 6(8):1045-9. PubMed ID: 2121192
[TBL] [Abstract][Full Text] [Related]
15. AZT (zidovudine) may act postintegrationally to inhibit generation of HIV-1 progeny virus in chronically infected cells.
Rooke R; Tremblay M; Wainberg MA
Virology; 1990 May; 176(1):205-15. PubMed ID: 1691885
[TBL] [Abstract][Full Text] [Related]
16. Synergistic stimulatory effects of tumour necrosis factor alpha and interferon gamma on replication of human immunodeficiency virus type 1 and on apoptosis of HIV-1-infected host cells.
Han X; Becker K; Degen HJ; Jablonowski H; Strohmeyer G
Eur J Clin Invest; 1996 Apr; 26(4):286-92. PubMed ID: 8732485
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human interferon-beta suppresses the replication of HIV and acts synergistically with AZT.
Williams GJ; Colby CB
J Interferon Res; 1989 Dec; 9(6):709-18. PubMed ID: 2514233
[TBL] [Abstract][Full Text] [Related]
18. Three-drug synergistic inhibition of HIV-1 replication in vitro by zidovudine, recombinant soluble CD4, and recombinant interferon-alpha A.
Johnson VA; Barlow MA; Merrill DP; Chou TC; Hirsch MS
J Infect Dis; 1990 Jun; 161(6):1059-67. PubMed ID: 2345291
[TBL] [Abstract][Full Text] [Related]
19. Interferon-alpha treatment leads to accumulation of virus particles on the surface of cells persistently infected with the human immunodeficiency virus type 1.
Yasuda Y; Miyake S; Kato S; Kita M; Kishida T; Kimura T; Ikuta K
J Acquir Immune Defic Syndr (1988); 1990; 3(11):1046-51. PubMed ID: 2213506
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of HIV-1 latency reactivation by dehydroepiandrosterone (DHEA) and an analog of DHEA.
Yang JY; Schwartz A; Henderson EE
AIDS Res Hum Retroviruses; 1993 Aug; 9(8):747-54. PubMed ID: 7692906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
